Jason Friday
Child & Adolescent Psychiatry · Gilbert, AZNPI 1134352933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 1,125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,125 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$2K
- Tris Pharma Inc$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Corium, LLC$1K
- Lundbeck LLC$1K
- plus $9K from 31 others
What the payments were for
- Food & beverage$18,17299%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$18,283 in reported general payments places this provider in the 95th percentile of 80 child & adolescent psychiatry providers in Arizona.
See all child & adolescent psychiatry providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $101,942 |
| VraylarCariprazine Hcl | 33 | $50,158 |
| Abilify MaintenaAripiprazole | 12 | $26,139 |
| TrintellixVortioxetine Hydrobromide | 11 | $8,298 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $729 |
| Methylphenidate Hcl | 13 | $719 |
| Bupropion XlBupropion Hcl | 27 | $664 |
| Mirtazapine | 14 | $411 |
| Lamotrigine | 20 | $385 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $380 |
| Alprazolam | 37 | $273 |
| Duloxetine Hcl | 21 | $237 |
| Trazodone Hcl | 26 | $225 |
| Diazepam | 20 | $204 |
| Lithium Carbonate ErLithium Carbonate | 13 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $466 | $101,94212 claims |
| AbbVieVraylar | $2,774 | $50,15833 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $1,597 | $26,13912 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $505 | $8,29811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 80 child & adolescent psychiatry providers in Arizona.
Other child & adolescent psychiatry in Gilbert
- Arashdeep GillGilbert$310
- Suzanne DonPhoenix$119K
- Ramiro GuillenScottsdale$31K
- Edward KuhnleyPrescott Valley$18K
- Linda KalivasScottsdale$13K
- Palpu HazelScottsdale$13K
- Melissa RamirezPhoenix$9K
- Kenneth ZwierScottsdale$7K
- Roya KarbakhshScottsdale$6K
- Fariba PfitznerScottsdale$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.